Recicort 1.77 mg/ml + 17.7 mg/ml ear drops, solution for dogs and cats

देश: आयरलैंड

भाषा: अंग्रेज़ी

स्रोत: HPRA (Health Products Regulatory Authority)

सक्रिय संघटक:

Triamcinolone acetonide; Salicylic acid

थमां उपलब्ध:

Le Vet Beheer B.V.

ए.टी.सी कोड:

QD07XB02

INN (इंटरनेशनल नाम):

Triamcinolone acetonide; Salicylic acid

डोज़:

1.77, 17.7 milligram(s)/millilitre

फार्मास्यूटिकल फॉर्म:

Ear drops, solution

प्रिस्क्रिप्शन प्रकार:

POM: Prescription Only Medicine as defined in relevant national legislation

चिकित्सीय समूह:

Cats, Dogs

चिकित्सीय क्षेत्र:

triamcinolone

चिकित्सीय संकेत:

Corticosteroid

प्राधिकरण का दर्जा:

Authorised

प्राधिकरण की तारीख:

2017-03-10

उत्पाद विशेषताएं

Health Products Regulatory Authority
26 November 2021
CRN00CDX9
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Recicort 1.77 mg/ml + 17.7 mg/ml ear drops, solution for dogs and cats
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
1 ml contains:
ACTIVE SUBSTANCES:
​
Triamcinolone acetonide
​
1.77 mg
​
Salicylic acid
​
17.7 mg
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Ear drops, solution.
Clear colourless solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs and cats.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of otitis externa.
Symptomatic treatment of seborrhoeic dermatitis of the auricle.
4.3 CONTRAINDICATIONS
Do not use in cases of hypersensitivity to corticosteroids, salicylic
acid or to any of the excipients.
Do not use in animals with perforated tympanic membrane. Do not use in
dogs with demodicosis.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
For an effective treatment of otitis externa it is essential that the
ear canal is meticulously cleaned and dried before first
treatment to remove cerumen and/or exudate. Excess hair around the
treatment area should be clipped if necessary.
For an effective treatment of seborrhoeic dermatitis existing scale
and or exfoliative debris should be removed. Hair
surrounding or covering the lesions may need to be clipped to enable
the veterinary medicinal product to reach the affected
skin.
Seborrhoeic dermatitis may be a primary disorder, but can also occur
as a result of underlying disorders or disease processes
(e.g. allergic disorders, endocrine disorders, neoplasia) while otitis
externa is only very rarely primary and occurs mainly as a
result of different underlying causes (predisposing and perpetuating
factors, neoplasia). Therefore, it is essential to identify any
underlying disease process and initiate specific treatment, if
considered necessary.
Furthermore, infections (bacterial, parasitic or fungal) commonly
occur concurrently with seborrhoeic dermatitis or otitis